Entering the Multi-omics and precision medicine era in cancer research
The Story, The Patient, The Activist
We wanted to start 2022 by reinforcing NeoGenomics Laboratories, Inc.’s promise to work toward state-of-the-art diagnostic and oncology testing for patients.
Perspectives on a ssPMA CDx submission
The proprietary, high sensitivity Sanger sequencing assay (LOD <1%), developed by NeoGenomics, was used in certain BeiGene Phase 2 and Phase 3 clinical studies to determine the MYD88 status of p
Talking Cancer: Conversations with Trailblazers, Advocates, Patients, and Medical Ambassadors
In the middle of the pandemic, GO2 Foundation for Lung Cancer appointed Dr. Jennifer King as their Chief Scientific Officer in May 2020.
Enabling Precision Medicine for Breast Cancer Patients
Approximately every 2 minutes, a woman in the U.S. is diagnosed with breast cancer1. This high prevalence has led to rigorous standards of practice, from diagnosis to treatment.
Talking Cancer: Conversations with Trailblazers, Advocates, Patients, and Medical Ambassadors
Madhushree Ghosh
Precision Medicine
Precision medicine reduces unnecessary risks to patients including hazardous side effects as well as ineffective treatments (“trial and error” medicine).
Genomics in Precision Medicine
We often hear “Don’t take anything personally”. However, that is not the case in terms of precision medicine. In 2015, the U.S. government launched the "Precision Medicine Initiative".